Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionLipe & Dalton
Latest Disclosed Ownership1,420 shares
Latest Disclosed Value $ 146
Lipe & Dalton reports 39.22% increase in ownership of ABL / Abbott Laboratories

On April 29, 2026 - Lipe & Dalton filed a 13F-HR form disclosing ownership of 1,420 shares of Abbott Laboratories (DE:ABL) valued at $126,124 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,020 shares of Abbott Laboratories. The current value of the position is $106,812 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F Abbott Laboratories cs 002824100 1,420 400 39.22 0 0.0764
2026-01-26 2025-12-31 13F Abbott Laboratories cs 002824100 1,020 -410 -28.67 0 0.0632
2026-01-26 2025-09-30 13F Abbott Laboratories cs 002824100 1,430 -300 -17.34 0 0.0951
2025-08-01 2025-06-30 13F Abbott Laboratories cs 002824100 1,730 0 0.00 0 0.1270
2025-05-05 2025-03-31 13F Abbott Laboratories cs 002824100 1,730 1,730 0 0.1281
2025-02-03 2024-12-31 13F Abbott Laboratories cs 002824100 0 -1,980 -100.00 0 0.0000
2024-11-04 2024-09-30 13F Abbott Laboratories cs 002824100 1,980 0 0.00 0 0.1142
2024-08-02 2024-06-30 13F Abbott Laboratories cs 002824100 1,980 -34 -1.69 0 0.1108
2024-05-07 2024-03-31 13F Abbott Laboratories cs 002824100 2,014 0 0.00 0 0.1181
2024-01-30 2023-12-31 13F Abbott Laboratories cs 002824100 2,014 0 0.00 0 0.1205
2023-11-03 2023-09-30 13F Abbott Laboratories cs 002824100 2,014 0 0.00 0 0.1174
2023-07-26 2023-06-30 13F Abbott Laboratories cs 002824100 2,014 0 0.00 0 0.1254
2023-05-02 2023-03-31 13F Abbott Laboratories CS 002824100 2,014 0 0.00 0 0.1169
2023-02-03 2022-12-31 13F Abbott Laboratories CS 002824100 2,014 -300 -12.96 0 -100.00 0.1272
2022-11-07 2022-09-30 13F Abbott Laboratories CS 002824100 2,314 0 0.00 224 -10.76 0.1405
2022-08-01 2022-06-30 13F Abbott Laboratories CS 002824100 2,314 0 0.00 251 -8.39 0.1469
2022-04-26 2022-03-31 13F Abbott Laboratories CS 002824100 2,314 0 0.00 274 -15.95 0.1338
2022-02-01 2021-12-31 13F Abbott Laboratories CS 002824100 2,314 34 1.49 326 21.19 0.1542
2021-11-01 2021-09-30 13F Abbott Laboratories cs 002824100 2,280 -150 -6.17 269 -4.61 0.1382
2021-08-02 2021-06-30 13F Abbott Laboratories CS 002824100 2,430 0 0.00 282 -3.09 0.1466
2021-04-30 2021-03-31 13F Abbott Laboratories CS 002824100 2,430 0 0.00 291 9.40 0.1615
2021-01-29 2020-12-31 13F Abbott Laboratories CS 002824100 2,430 300 14.08 266 14.66 0.1635
2020-10-30 2020-09-30 13F Abbott Laboratories CS 002824100 2,130 0 0.00 232 18.97 0.1613
2020-08-07 2020-06-30 13F Abbott Laboratories cs 002824100 2,130 0 0.00 195 16.07 0.1416
2020-05-01 2020-03-31 13F Abbott Laboratories cs 002824100 2,130 0 0.00 168 -9.19 0.1421
2020-01-21 2019-12-31 13F Abbott Laboratories cs 002824100 2,130 0 0.00 185 3.93 0.1226
2019-11-07 2019-09-30 13F Abbott Laboratories cs 002824100 2,130 -20 -0.93 178 -1.66 0.1299
2019-07-24 2019-06-30 13F Abbott Laboratories cs 002824100 2,150 0 0.00 181 5.23 0.1294
2019-04-30 2019-03-31 13F Abbott Laboratories cs 002824100 2,150 0 0.00 172 10.26 0.1265
2019-02-08 2018-12-31 13F Abbott Laboratories cs 002824100 2,150 0 0.00 156 -1.27 0.1271
2018-11-05 2018-09-30 13F Abbott Laboratories cs 002824100 2,150 0 0.00 158 20.61 0.1078
2018-08-06 2018-06-30 13F Abbott Laboratories cs 002824100 2,150 150 7.50 131 9.17 0.0964
2018-05-04 2018-03-31 13F Abbott Laboratories cs 002824100 2,000 20 1.01 120 6.19 0.0858
2018-02-13 2017-12-31 13F Abbott Laboratories cs 002824100 1,980 0 0.00 113 6.60 0.0781
2017-11-03 2017-09-30 13F Abbott Laboratories cs 002824100 1,980 0 0.00 106 10.42 0.0745
2017-08-08 2017-06-30 13F Abbott Laboratories cs 002824100 1,980 0 0.00 96 9.09 0.0622
2017-05-08 2017-03-31 13F Abbott Laboratories cs 002824100 1,980 1,980 88 0.0637
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.